NeoGenomics names Warren Stone, its current president and COO, as incoming CEO, effective Jan. 4, 2027. Current CEO Tony Zook will shift to executive chairman the same day. The move follows years of internal planning, the company says, and emphasizes continuity in strategy. Stone joined NeoGenomics in 2022 and has held leadership roles including president of clinical services. Zook says the two will work closely through the transition and continue collaborating afterward.

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.